3 ms·
Just one data point, I’m from Argentina, we drink Mate here (as in yerba mate with a straw) the custom is to drink it very hot (around 80 deg celcius) and never
by gbaygon 8y ago
Just one data point, I’m from Argentina, we drink Mate here (as in yerba mate with a straw) the custom is to drink it very hot (around 80 deg celcius) and never knew any one with oesophageal cancer. You start drinking it as a child with sugar and cold (60 deg) and you just get used to it. After a couple of years you drink it bitter (Mate Amargo) and hot.
- asdf333 8y agoactually i think there was some research showing yerba mate drinkers had higher incidences of cancer due to the hotness of the liquid. https://www.ncbi.nlm.nih.gov/m/pubmed/19695149/ https://www.ncbi.nlm.nih.gov/m/pubmed/19695149/
- sidesentists 8y agoI actually thought they were linking it to the temperature + the fact that mate is often smoked during processing (which is one reason I think I actually like the flavor unfortunately)
- rasengan0 8y agoI stopped drinking my beloved Rosamonte especial (smoky) mainly out of concern for carcinogenic compounds (PAHs) and less for the boiling temperatures. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525749/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525749/ As for the present prospective cohort survey https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.32220 https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.32220, I'm surprised the actual tea (processing method/brand) was not listed as a confounding factor. They mention PAHs but to the extent of their generic use of the term 'tea' throughout the Discussion section makes me question the utility: "However, tea also contains several other compounds with unknown effects, and some potentially carcinogenic compounds may be introduced to tea when being processed (such as possible contamination of black tea with PAHs)"
- arisAlexis 8y agothe fact that you don't know anyone with a rare cancer doesn't mean that the chances are not doubled. empirical one man observations cannot contradict a study even if the study is flawed